✦ LIBER ✦

Rationale and design of a randomized clinical trial of β-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome

✍ Scribed by Ronald V. Lacro; Harry C. Dietz; Lisa M. Wruck; Timothy J. Bradley; Steven D. Colan; Richard B. Devereux; Gloria L. Klein; Jennifer S. Li; L. LuAnn Minich; Stephen M. Paridon; Gail D. Pearson; Beth F. Printz; Reed E. Pyeritz; Elizabeth Radojewski; Mary J. Roman; J. Philip Saul; Mario P. Stylianou; Lynn Mahony

Book ID: 116191072
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 185 KB
Volume: 154
Category: Article
ISSN: 1097-6744
DOI: 10.1016/j.ahj.2007.06.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and design of a randomized cli

Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensin II receptor blocker therapy versus placebo in individuals with Marfan syndrome

✍ Delphine Detaint; Philippe Aegerter; Florence Tubach; Isabelle Hoffman; Henri Pl 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 809 KB

Interim evidence of the renoprotective e

Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study

✍ Yasuhiko Iino; Matsuhiko Hayashi; Tetsuya Kawamura; Tatsuo Shiigai; Yasuhiko Tom 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 613 KB